Skip to main content
. 2024 Aug 2;16(15):2752. doi: 10.3390/cancers16152752

Figure 3.

Figure 3

Chemical structures of the drug tested in completed and ongoing clinical trials that evaluate(d) IDH inhibitors for the treatment of glioma and cholangiocarcinoma. The 2D structure figures were obtained from https://pubchem.ncbi.nlm.nih.gov.